Age-induced methylmalonic acid accumulation promotes tumor progression and aggressiveness
Gomes, A. P.; Ilter, D.; Low, V.; Endress, J.; Fernandez-Garcia, J.; Rosenzweig, A.; Schild, T.; Broekaert, D.; Ahmed, A.; Planque, M.; Elia, I.; Han, J.; Kinzig, C.; Mullarky, E.; Mutvei, A.; Asara, J. M.; deCabo, R.; Cantley, L. C.; Dephoure, N.; Fendt, S.-M.; Blenis, J.
Show abstract
From age 65 onwards, the risk of cancer incidence and associated mortality is substantially higher1-3. Nonetheless, our understanding of the complex relationship between age and cancer is still in its infancy4. For decades, the link has largely been attributed to increased exposure time to mutagens in older individuals. However, this view does not account for the well-established role of diet, exercise and small molecules that target the pace of metabolic aging5-8. Here, we show that metabolic alterations that occur with age can render a systemic environment favorable to progression and aggressiveness of tumors. Specifically, we show that methylmalonic acid (MMA), a by-product of propionate metabolism, is significantly up-regulated in the serum of older people, and functions as a mediator of tumor progression. We traced this to the induction of SOX4 and a consequent transcriptional reprogramming that can endow cancer cells with aggressive properties. Thus, accumulation of MMA represents a novel link between aging and cancer progression, implicating MMA as a novel therapeutic target for advanced carcinomas.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Accelerated cognitive decline in obese mouse model of Alzheimer's disease is linked to sialic acid-driven immune deregulation 98%
- SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade 98%
- ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent Transcription Replication Conflicts in Triple Negative Breast Cancer 98%
Similar papers in this journal
- Extracellular 2’3’-cGAMP is an immunotransmitter produced by cancer cells and regulated by ENPP1 98%
- The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1 97%
- Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response 97%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.